ErgoNex Pharma GmbH

In Vitro Diagnostics Acquisitions / In Vitro Diagnostics Aterovax SA Bertin Technologies SPI-Bio Aterovax SA (cardiovascular disease diagnostics) has granted SPI-Bio ( Bertin Technologies

Pfizer has acquired the rights to the pulmonary arterial hypertension (PAH) drug candidate terguride from Swiss firm Ergonex Pharma. The deal, terms of which have not been disclosed, gives Pfizer the